Correlation Between Newron Pharmaceuticals and HBM Healthcare
Can any of the company-specific risk be diversified away by investing in both Newron Pharmaceuticals and HBM Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Newron Pharmaceuticals and HBM Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Newron Pharmaceuticals SpA and HBM Healthcare Investments, you can compare the effects of market volatilities on Newron Pharmaceuticals and HBM Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Newron Pharmaceuticals with a short position of HBM Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Newron Pharmaceuticals and HBM Healthcare.
Diversification Opportunities for Newron Pharmaceuticals and HBM Healthcare
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Newron and HBM is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Newron Pharmaceuticals SpA and HBM Healthcare Investments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HBM Healthcare Inves and Newron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Newron Pharmaceuticals SpA are associated (or correlated) with HBM Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HBM Healthcare Inves has no effect on the direction of Newron Pharmaceuticals i.e., Newron Pharmaceuticals and HBM Healthcare go up and down completely randomly.
Pair Corralation between Newron Pharmaceuticals and HBM Healthcare
Assuming the 90 days trading horizon Newron Pharmaceuticals SpA is expected to generate 3.71 times more return on investment than HBM Healthcare. However, Newron Pharmaceuticals is 3.71 times more volatile than HBM Healthcare Investments. It trades about 0.31 of its potential returns per unit of risk. HBM Healthcare Investments is currently generating about 0.23 per unit of risk. If you would invest 823.00 in Newron Pharmaceuticals SpA on September 3, 2025 and sell it today you would earn a total of 1,065 from holding Newron Pharmaceuticals SpA or generate 129.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Newron Pharmaceuticals SpA vs. HBM Healthcare Investments
Performance |
| Timeline |
| Newron Pharmaceuticals |
| HBM Healthcare Inves |
Newron Pharmaceuticals and HBM Healthcare Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Newron Pharmaceuticals and HBM Healthcare
The main advantage of trading using opposite Newron Pharmaceuticals and HBM Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Newron Pharmaceuticals position performs unexpectedly, HBM Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HBM Healthcare will offset losses from the drop in HBM Healthcare's long position.| Newron Pharmaceuticals vs. Galenica Sante AG | Newron Pharmaceuticals vs. BB Biotech AG | Newron Pharmaceuticals vs. Idorsia | Newron Pharmaceuticals vs. HBM Healthcare Investments |
| HBM Healthcare vs. Galenica Sante AG | HBM Healthcare vs. BB Biotech AG | HBM Healthcare vs. Idorsia | HBM Healthcare vs. Xlife Sciences AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |